EnteroBiotix

Activities: Research & Development Microbiology

Trending Articles

  1. The role of traceability in the nutraceutical supply chain The exponential growth of the nutraceutical sector, combined with the unprecedented growth in online marketplaces, makes nutraceuticals highly vulnerable to vast counterfeiting...
  2. Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
  3. BENEO presents new toolbox of non-GMO vegetal proteins for pet food Range of proteins allows manufacturers to cater for increasing demand for natural, plant-based and sustainable pet food products
  4. The perfect pair: how vitamins K2 and D3 combine to support health and well-being Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
  5. A date with coffee: part I NBR’s Dr Kevin Robinson recently met Mr Ido Zimet, a producer of date seed coffee in Israel and cofounder of Coffee Date, LLC, in the USA for a brew and a fascinating chat...

Upcoming event

Vitafoods Europe

14–16 May 2024 | Exhibition | Palexpo, Geneva See all

Related Content

Research & Development

EnteroBiotix partners with Imperial College London on microbiome therapeutics

Partnership includes a Phase II clinical trial using microbiome therapeutics funded by the Medical Research Council (MRC) aiming to potentiate allo-HCT in patients suffering from haematological malignancy
Finance

EnteroBiotix raises $21m in series A financing

The company produces therapeutics designed to holistically enhance the gut microbiome
Manufacturing

EnteroBiotix secures MHRA licence for clinical trial manufacturing

The Scottish microbiome specialists is also working on creating a common European regulatory framework for microbiome ecosystem-based therapeutics
Subscribe now